Physician profile
Larina Gutenberg
NPI 1194994681
$5,306.73
in general payments reported to CMS, 2019-2025
26 companies · $319 in 2025
The $319 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,385 · 2020: $235 · 2021: $612 · 2022: $465 · 2023: $437 · 2024: $855 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,577 · Education: $33.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,576.55 |
| Education | $33.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $2,142.13 | 2019 | |
| Abbott Laboratories | $628.99 | 2021-2025 | Eterna, Proclaim, Ionicrf |
| Si-Bone, INC. | $460.23 | 2019-2024 | |
| Boston Scientific Corporation | $319.77 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Abbvie INC. | $298.14 | 2023-2025 | |
| Saluda Medical Americas, INC. | $211.79 | 2024 | Evoke |
| Nevro Corp. | $185.34 | 2021-2023 | Senza |
| Globus Medical, INC. | $173.83 | 2025 | Senza |
| Medtronic, INC. | $165.46 | 2021-2022 | |
| Medtronic USA, INC. | $118.36 | 2019-2020 | |
| Novo Nordisk INC | $118.13 | 2021 | |
| Pfizer INC. | $97.09 | 2019-2020 | |
| Almatica Pharma LLC | $59.74 | 2021-2023 | Gralise |
| Allergan, INC. | $43.00 | 2019-2021 | |
| Spinal Simplicity, LLC | $38.91 | 2024 | Ha Minuteman G3-R |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $35.00 | 2022-2023 | Kloxxado |
| Scilex Pharmaceuticals INC. | $32.76 | 2023-2024 | Ztlido |
| Mml US, INC. | $32.25 | 2023 | Reactiv8 |
| Painteq LLC | $25.31 | 2023 | Painteq |
| Biotronik Nro, INC. | $23.62 | 2024 | Prospera |
| Relievant Medsystems, INC. | $22.40 | 2021 | |
| Assertio Therapeutics, INC. | $19.21 | 2019 | |
| Ibsa Pharma INC. | $16.98 | 2024 | Licart, Tirosint |
| Zyla Life Sciences, INC. | $12.94 | 2019 | |
| Collegium Pharmaceutical, INC. | $12.79 | 2021 | |
| Vertical Pharmaceuticals, LLC | $12.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larina Gutenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.